- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05868421
Veteran Social Support for Enhancing Use of Smoking Cessation Treatment (VAntage)
Veteran Social Support Intervention for Enhancing Smoking Treatment Utilization and Cessation
Study Overview
Status
Conditions
Detailed Description
Background: Enhancing access and use of evidence-based tobacco cessation treatments and eliminating tobacco-related health disparities are top national and VA health services priorities. The prevalence of tobacco use is greater among Veterans compared to non-Veterans. From 2010-2015, 29% of women and 21% of male Veterans reported current cigarette smoking. Evidence-based cessation treatments (EBCTs) such as, tobacco quitlines, behavioral counseling, and pharmacotherapy, are greatly underutilized by Veteran smokers. Gaps remain in reaching women Veterans and use of existing social support networks to enhance use of EBCTs and cessation among Veterans.
Specific Aims. Aim 1: To evaluate the impact of the social support intervention on Veteran smokers' use of EBCT. Aim 2: To examine the effectiveness of the social support intervention on the biochemically confirmed 7-day point prevalence cigarette smoking abstinence. Aim 3: To explore potential moderators (e.g., smoker gender, SP tobacco use status) of intervention effects on study outcomes. Aim 4: To conduct a process evaluation assessing implementation outcomes (reach, adoption, fidelity) of the social support intervention and multilevel factors that may influence implementation.
Methods: The investigators will conduct a pragmatic randomized controlled trial (RCT) within the national VHA health system to evaluate the effectiveness of a social support intervention compared with a control condition on utilization of EBCT among VHA-enrolled smokers. Veteran smokers, regardless of level of readiness to quit, will be identified nationally using the VHA electronic health record and proactively recruited. Interested smokers will be asked to identify a support person (SP) who will enroll. Participants will be randomized as smoker-SP dyads to the intervention (n= 594 dyads) or control condition (n= 594 dyads). All smokers will receive written resources and information on EBCTs. All SP participants will receive written materials. SP participants assigned to the intervention group will additionally receive a 1-call coaching session. Assessments for dyads in both study groups will be conducted at baseline, 3-, and 6-months post-randomization.
Innovation and Impact: This project is innovative for evaluating social support networks as a proactive outreach approach to enhance cessation treatment utilization among Veteran smokers. The role of social network influences and social support on successful smoking cessation is established. Based on Cohen's theory of social support, the team developed a social support intervention for diverse family members, friends, and other adults who wanted to help a smoker quit. The intervention consists of written materials and a 1-call, 15-25 minute coaching session. It is expected to be especially beneficial for Veteran smokers who might not otherwise access cessation treatment. Because the prior VHA trials enrolled about 94% men and the higher smoking rates among women, the investigators will oversample women to enroll an equal number of men and women smokers. This study contributes to VA HSR&D's priority initiatives for enhancing treatment access and women's health and is significant because it will advance research on the role of partnering with Veterans' families and/or important others to enhance access to VA healthcare and population-specific treatments, especially women Veterans. The potential reach and public health impact of an effective social support intervention for the Veteran tobacco user population is considerable.
Implementation/Next Steps: Next steps depend on the actual results, but the investigators expect findings to be important to VA leaders, the VA Women's Health Research Consortium and the Veteran community. The investigators will maintain communication throughout the project with VA program partners to share findings in a timely manner. The investigators will collaborate with CCDOR's Veteran Engagement Panel on development of patient-centered dissemination approaches and recommendations for future intervention adaptations and/or implementation.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Mariah Branson, BA
- Phone Number: 314920 (612) 467-2000
- Email: Mariah.Branson@va.gov
Study Locations
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55417-2309
- Recruiting
- Minneapolis VA Health Care System, Minneapolis, MN
-
Contact:
- Mariah Branson, BA
- Phone Number: 314920 612-467-2000
- Email: Mariah.Branson@va.gov
-
Principal Investigator:
- Steven S. Fu, MD MSCE
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Veteran Inclusion Criteria
- Smoked 1 cigarettes over the past 30 days, even a puff
- If using other tobacco or nicotine products, cigarettes are the main product used
- Able to identify one adult family member or friend (SP) with whom they have contact (of any form) at least 3 times per week who will enroll Veteran Support Person Inclusion Criteria
- Willing to support the Veteran smoker
- Have to have access to any type of phone (or tablet for video call) for delivery of the SP intervention
Exclusion Criteria:
Veteran Exclusion Criteria
- Have used cessation medications or a stop smoking program within the past 3 months
- Have no valid phone contact information
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Support Person Coaching Call and Written Materials
Support persons will receive written material resources on support strategies to stop smoking, and resources on how to stop smoking.
Support person participants assigned to the intervention group will additionally receive a 1-call coaching session about 15-25 minutes in duration on how to support their Veteran smoker.
The coaching session will be delivered by research staff by phone or video call.
Veteran smokers will receive written smoking cessation resource and referral information for VHA and non-VHA EBCT options.
|
Support person participants assigned to the intervention group will additionally receive a 1-call coaching session about 15-25 minutes in duration on how to support their Veteran smoker.
The session will be delivered by research staff by phone or video call.
Support persons in the intervention group and the control/no intervention group will receive existing written material resources on support strategies to stop smoking, and resources on how to stop smoking by postal mail or email.
Other Names:
Written materials covering tips on effective supportive strategies for smoking cessation
Other Names:
Written materials on resource and referral information for VHA and non-VHA EBCT options
|
Active Comparator: Written Materials Only
Support persons will receive written material resources on support strategies to stop smoking, and resources on how to stop smoking.
Veteran smokers will receive written smoking cessation resource and referral information for VHA and non-VHA EBCT options.
|
Written materials covering tips on effective supportive strategies for smoking cessation
Other Names:
Written materials on resource and referral information for VHA and non-VHA EBCT options
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Use of Any Evidence-Based Cessation Treatments (EBCTs)
Time Frame: 6 months
|
The primary outcome will be use of any EBCT assessed at the 6 month follow-up: medication, behavioral intervention, or combination using both self-report and VHA administrative data.
Data will be extracted from the VA Corporate Data Warehouse (CDW) to assess VA treatment use.
VA outpatient prescription records will be used to assess receipt and amount of pharmacotherapy (bupropion, varenicline, nicotine replacement therapy (NRT)) and VA outpatient encounters associated with smoking cessation will be assed using stop codes (i.e., 707 and 708) and/or diagnoses treated for nicotine dependence (i.e., ICD10-F17.XX) to assess behavioral interventions.
Use of QuitVET, SmokefreeVET, Department of Defense (DoD) and non-VHA treatment use will be assessed using self-report.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Use of Any Evidence-Based Cessation Treatments (EBCTs)
Time Frame: 3 months
|
use of any EBCT: medication, behavioral intervention, or combination using both self-report and VHA administrative data
|
3 months
|
Self-reported 7-day point prevalence cigarette smoking abstinence
Time Frame: 6 months
|
Any cigarette smoking in the past 7 days, even a puff
|
6 months
|
Self-reported 7-day point prevalence cigarette smoking abstinence
Time Frame: 3 months
|
Any cigarette smoking in the past 7 days, even a puff
|
3 months
|
Prolonged smoking abstinence
Time Frame: 6 months
|
Self-report of no smoking through 6-months follow-up
|
6 months
|
Biochemically confirmed 7-day point prevalence cigarette smoking abstinence
Time Frame: 6 months
|
For this trial, the focus with respect to abstinence is on combustible cigarette smoking.
The investigators will assess self-reported 7-day point-prevalence abstinence 6-months and obtain biochemical verification at 6 months, defined as a negative carbon monoxide (CO) breath test (0-6 ppm) or negative salivary cotinine (< 30 ng/ml).
Biochemical verification will be obtained using expired CO by mailing an iCO Smokerlyzer®, a small, portable, handheld breath CO monitor that connects to a mobile device or tablet, as the primary modality because carbon monoxide is not confounded by use of NRT, smokeless tobacco or e-cigarettes.
|
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Steven S. Fu, MD MSCE, Minneapolis VA Health Care System, Minneapolis, MN
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IIR 20-117
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking Cessation
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
Nabi BiopharmaceuticalsNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco CessationUnited States
-
Claremont Graduate UniversityNational Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, CigaretteUnited States
-
Heidelberg UniversityPfizerTerminatedSmoking | Smoking Cessation | Tobacco Use CessationGermany
-
Mayo ClinicNational Institute on Drug Abuse (NIDA)CompletedSmoking | Smoking Cessation | Tobacco Use | Tobacco Smoking | Tobacco Use Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
University of MiamiFlorida Department of HealthRecruitingSmoking Cessation | Tobacco Smoking | Tobacco Use CessationUnited States
-
University of VermontMayo Clinic; Alaska Native Tribal Health ConsortiumTerminatedSmoking | Smoking CessationUnited States
-
University of Wisconsin, MadisonCentiment LLCCompletedSmoking | Smoking CessationUnited States
-
Yale UniversityCompletedSmoking | Smoking CessationUnited States
-
Johns Hopkins UniversityMaryland Department of Health and Mental HygieneCompletedCOach2Quit TRIAL: Assessing a Prototype Personal Carbon Monoxide Monitor for Smoking Cessation (C2Q)Smoking | Smoking CessationUnited States
Clinical Trials on Support Person Coaching Call
-
Minneapolis Veterans Affairs Medical CenterRecruitingSmoking CessationUnited States
-
University of Wisconsin, MadisonThrive FoundationRecruiting
-
Norges idrettshøgskoleKristiania University College; ABEL TechnologiesRecruiting
-
Naestved HospitalUniversity of CopenhagenCompletedLung Cancer | Diagnoses Disease | Psychosocial StressorDenmark
-
The University of Texas Health Science Center,...National Cancer Institute (NCI); Washington University School of Medicine; Emory... and other collaboratorsCompletedChronic DiseaseUnited States
-
University of North Carolina, Chapel HillNational Cancer Institute (NCI); The University of Texas Health Science Center... and other collaboratorsCompletedChronic DiseaseUnited States
-
Emory UniversityNational Cancer Institute (NCI); The University of Texas Health Science Center... and other collaboratorsCompletedChronic DiseasesUnited States
-
Planned Parenthood of Southwest and Central FloridaCompleted
-
McGill University Health Centre/Research Institute...Canadian Institutes of Health Research (CIHR); University of AlbertaActive, not recruitingParent-Child Relations | Autism Spectrum Disorder | Parenting | Mental Health Wellness 1 | Parent-child Problem | Child Development Disorder | Child Developmental DelayCanada
-
University of BucharestRecruitingMental Health Wellness 1 | Well-Being, PsychologicalRomania